loadpatents
name:-0.043004989624023
name:-0.010633945465088
name:-0.020653963088989
MACLEOD; Angus Patent Filings

MACLEOD; Angus

Patent Applications and Registrations

Patent applications and USPTO patent grants for MACLEOD; Angus.The latest application filed is for "macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitors".

Company Profile
11.9.33
  • MACLEOD; Angus - Cambridge GB
  • MacLeod; Angus - Saffron Walden N/A GB
  • Macleod; Angus - Essex GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Macrocyclic Sulfonylurea Derivatives Useful As Nlrp3 Inhibitors
App 20220289766 - COOPER; Matthew ;   et al.
2022-09-15
Nlrp3 Inhibitors
App 20220289692 - MILLER; David ;   et al.
2022-09-15
Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors
Grant 11,370,776 - Cooper , et al. June 28, 2
2022-06-28
Novel Sulfonamideurea Compounds
App 20220194923 - COOPER; Matthew ;   et al.
2022-06-23
Nlrp3 Inflammasome Inhibition
App 20220163539 - COOPER; Matthew ;   et al.
2022-05-26
Nlrp3 Inhibitors
App 20220106289 - COOPER; Matthew ;   et al.
2022-04-07
Novel Sulfoneurea Compounds
App 20220106288 - MACLEOD; Angus ;   et al.
2022-04-07
Novel Compounds
App 20210347737 - COOPER; Matthew ;   et al.
2021-11-11
Phenylsulfonylurea Derivatives Useful As Nlrp3 Inhibitors
App 20210332020 - COOPER; Matthew ;   et al.
2021-10-28
Sodium Salt Of N-((1,2,3,5,6,7-Hexahydro-S-Indacen-4-Yl) Carbamoyl) -1 -Isopropyl-1 H-Pyrazole-3-Sulfonamide
App 20210315862 - MILLER; David ;   et al.
2021-10-14
Novel Compounds
App 20210261512 - MILLER; David ;   et al.
2021-08-26
Phenylsulfonylurea Derivatives Useful As Nlrp3 Inhibitors
App 20210147349 - COOPER; Matthew ;   et al.
2021-05-20
Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors
App 20210130359 - COOPER; Matthew ;   et al.
2021-05-06
Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors
App 20210130329 - COOPER; Matthew ;   et al.
2021-05-06
Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors
App 20210122716 - COOPER; Matthew ;   et al.
2021-04-29
Novel Sulfonamide Carboxamide Compounds
App 20210122739 - COOPER; Matthew ;   et al.
2021-04-29
Sodium salt of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazo- le-3-sulfonamide
Grant 10,973,803 - Miller , et al. April 13, 2
2021-04-13
Novel Sulfonamide Carboxamide Compounds
App 20200361895 - COOPER; Matthew ;   et al.
2020-11-19
Novel Sulfonamide Carboxamide Compounds
App 20200354341 - COOPER; Matthew ;   et al.
2020-11-12
Novel Sulfonamide Carboxamide Compounds
App 20200331850 - MILLER; David ;   et al.
2020-10-22
Novel Sulfonamide Carboxamide Compounds
App 20200317637 - COOPER; Matthew ;   et al.
2020-10-08
Novel Sulfonamide Carboxamide Compounds
App 20200291003 - COOPER; Matthew ;   et al.
2020-09-17
Sulfonylureas And Sulfonylthioureas As Nlrp3 Inhibitors
App 20200270227 - COOPER; Matthew ;   et al.
2020-08-27
Sodium Salt Of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1 -isopropyl-1 H-pyrazole-3-sulfonamide
App 20200237723 - MILLER; David ;   et al.
2020-07-30
Novel Sulfonamide Carboxamide Compounds
App 20200216389 - MILLER; David ;   et al.
2020-07-09
Substituted imidazo[1,2-a]pyrazine compounds useful for the treatment of viral infections
Grant 8,362,018 - MacLeod , et al. January 29, 2
2013-01-29
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
Grant 8,178,530 - Andrews , et al. May 15, 2
2012-05-15
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
Grant 8,173,656 - Andrews , et al. May 8, 2
2012-05-08
Imidazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases
App 20110218178 - Andrews; Martin James Inglis ;   et al.
2011-09-08
Triazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases
App 20110178067 - Andrews; Martin James Inglis ;   et al.
2011-07-21
Imidazopyrazine Compounds
App 20110166147 - Macleod; Angus ;   et al.
2011-07-07
Imidazo [2,1-b] Quinazolin-2-one Derivatives And Their Use As Platelet Anti-aggregative Agents
App 20110152298 - Golding; Bernard T. ;   et al.
2011-06-23
Substituted Quinazolines
App 20110130413 - Golding; Bernard ;   et al.
2011-06-02
Imidazolopyrazine Compounds Useful For The Treatment Of Degenerative And Inflammatory Diseases
App 20110092497 - Andrews; Martin James Inglis ;   et al.
2011-04-21
Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
Grant 7,915,256 - Andrews , et al. March 29, 2
2011-03-29
Imidazoquinazoline Derivatives As Anagrelide Analogues For The Treatment Of Myeloprolific Diseases And Thrombotic Diseases
App 20110071173 - Golding; Bernard ;   et al.
2011-03-24
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
Grant 7,893,058 - Andrews , et al. February 22, 2
2011-02-22
Triazolopyrazine Compounds Useful For The Treatment Of Degenerative & Inflammatory Diseases
App 20100298300 - Andrews; Martin James Inglis ;   et al.
2010-11-25
Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
Grant 7,501,411 - Andrews , et al. March 10, 2
2009-03-10
Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
App 20080090818 - Andrews; Martin James Inglis ;   et al.
2008-04-17
Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
App 20070281943 - Andrews; Martin James Inglis ;   et al.
2007-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed